Ignite Creation Date:
2025-12-24 @ 11:54 AM
Ignite Modification Date:
2026-01-10 @ 1:21 PM
Study NCT ID:
NCT01537861
Status:
TERMINATED
Last Update Posted:
2015-01-26
First Post:
2012-02-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Sponsor:
Washington University School of Medicine
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: